Pharma
Nxera Pharma receives approval of QUVIVIQ (daridorexant) in Japan for the treatment of insomnia
The approval of QUVIVIQ™, a novel dual orexin receptor antagonist, is based on robust clinical efficacy and safety data, including from a Phase 3 trial in Japan that met all primary and secondary endpoints Plans to make QUVIVIQ available as soon as possible to insomnia patients in Japa...
Teaching the next generation of innovators...
Why does the planet need entrepreneurship? What can the next generation of innovators learn from big businesses? ...
Give your cleanroom the TLC it needs with Guardtech’s first-class decontamination programmes and elite furniture fit-outs
The Guardtech Group are urging clients to ensure their controlled environments are free of contamination and fully equipped to deliver the best results ...
Living with ILD: A typical patient journey
Interstitial lung diseases (ILDs) are a group of disorders characterised by scarring and inflammation of the lung interstitium, common examples of which include idiopathic pulmonary fibrosis (IPF)and sarcoidosis. ILD is a challenging condition given the progressive nature of the disease...
Isopod Rapid Cleanrooms – providing small-scale segregation solutions for larger turnkey projects
The Guardtech Group’s modular cleanroom pod systems are the perfect accompaniment to their major Cleanroom Solutions facility installations ...
Join the first ever Innovation Conference held under the auspices of the Global Africa Initiative
The Trade Connect Cambridge Conferences is just around the corner, and we’re excited to invite you to be a part of this groundbreaking event. Scheduled for Saturday 5th October 2024 (11am-7pm) at Robinson College, University of Cambridge CB3 9AN (Crausaz Wordsworth Building, Adams Road)...
Approaching the final frontier: Are we in a golden decade of drug development for the central nervous system?
In this CRA Insights, the authors Will Foster, Kees Chamberlain, Joanne Clark, and Carl Lottig recount the recent scientific and technological advances in drug development in the central nervous system (CNS). CNS disorders impose a significant burden on patients, with the global impact ...
One Region – One Health
Context: One Health is described by the WHO as an integrated, unifying approach to balance and optimize the health of people, animals and the environment. The challenges of supporting human longevity encompass many aspects of this such as the development of affordable curative medicines...
HOPE: Cleanroom Solutions facilitating greatness with elite large-scale turnkey construction builds
Guardtech Group’s complex cleanroom facility construction brand celebrating their role as facilitators of groundbreaking Life Science and R&D innovation ...
Meet Cambridge helps to bring international neurotrauma conference to the city
The official bureau for conferences and events in Cambridge and the surrounding area is seeing the culmination of five years’ preparation as partner to the organising committee for one of the world’s largest medical conferences in its field. ...